WSMoreOrLess: Antibiotics and the problem of the broken market
It’s a life and death situation – the world is at its last line of defence against some pretty nasty bacteria and there are no new antibiotics. But it’s not the science that’s the big problem, it the economics. Despite the $40 billion market worldwide there’s no money to be made in antibiotics so big pharma have all but stopped their research. Why is this and how do we entice them back in? Wesley Stephenson finds out. (Image: Computer artwork of bacteria - credit: Science Photo Library)
2016-02-26
9 min
Available Results
Generated results are saved to the knowledge database for reuse and search.
No generated results are available for this episode yet.
Extract Knowledge
Pick what you want extracted first. Model, scope, and chapter options appear after a template is selected.
Generated results for public episodes are saved to the knowledge database so they can be reused and searched later.
Transcript
No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in
Chapters
No chapters available.